Treats Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive. ANDA 203906, held by Amneal Pharms. Aripiprazole.
As of Nov 16, 2026, ANDA 203906 (Aripiprazole), held by Amneal Pharms, was first approved by FDA on Aug 14, 2015, with 8 approved supplements and 0 published complete response letters.
Aripiprazole oral solution is indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole oral solution is an atypical antipsychotic. The oral formulations are indicated for: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s disorder
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Aripiprazole1MG/ML · solution;oral | Aripiprazole | Rx |
| Jan 24, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jan 13, 2025 | Supplement 15Labeling · Standard review | Approved | None posted |
| May 27, 2022 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 6, 2020 | Supplement 8Labeling · Standard review | Approved | None posted |
| Dec 10, 2019 | Supplement 7Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 4Labeling · Standard review | Approved | None posted |
| Feb 1, 2017 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 18, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Aug 14, 2015 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters